BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35663313)

  • 1. Corrigendum: The Risk Stratification of Papillary Thyroid Cancer With Bethesda Category III (Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance) by Thyroid Fine-Needle Aspiration Could Be Assisted by Tumor Size for Precision Treatment.
    Zha X; Miao Z; Huang X; Wang X; Xie R; Jin J; Zou D; Yang P; Huang Y
    Front Endocrinol (Lausanne); 2022; 13():911963. PubMed ID: 35663313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Risk Stratification of Papillary Thyroid Cancer With Bethesda Category III (Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance) by Thyroid Fine-Needle Aspiration Could Be Assisted by Tumor Size for Precision Treatment.
    Zha X; Miao Z; Huang X; Wang X; Xie R; Jin J; Zou D; Yang P; Huang Y
    Front Endocrinol (Lausanne); 2022; 13():822423. PubMed ID: 35197932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.
    Kim SJ; Roh J; Baek JH; Hong SJ; Shong YK; Kim WB; Song DE
    Cytopathology; 2017 Feb; 28(1):65-73. PubMed ID: 27245883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.
    Lim JXY; Nga ME; Chan DKH; Tan WB; Parameswaran R; Ngiam KY
    Thyroid; 2018 Apr; 28(4):511-521. PubMed ID: 29596039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and associated malignancy of Bethesda category III cytologies of thyroid nodules assigned to the "cytological atypia" or "architectural atypia" groups.
    García Pascual L; Surralles ML; Morlius X; Garcia Cano L; González Mínguez C
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):577-583. PubMed ID: 30262240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
    Gan TR; Nga ME; Lum JH; Wong WM; Tan WB; Parameswaran R; Ngiam KY
    Cancer Cytopathol; 2017 Apr; 125(4):245-256. PubMed ID: 28192631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
    Hyeon J; Ahn S; Shin JH; Oh YL
    Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach to Bethesda system category III thyroid nodules according to US-risk stratification.
    Kim J; Shin JH; Oh YL; Hahn SY; Park KW
    Endocr J; 2022 Jan; 69(1):67-74. PubMed ID: 34408101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance category in ultrasound-guided thyroid fine-needle aspiration in a large referral cancer center.
    Gan Q; Edeiken BS; Chen MM; Grubbs EG; Busaidy NL; Zafereo M; Perrier ND; Gule-Monroe MD; Krishnamurthy S
    J Am Soc Cytopathol; 2019; 8(6):309-316. PubMed ID: 31526696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of thyroid nodules classified as Bethesda category III on cytology and their malignancy rate: An institutional experience.
    Almahari SA; Harb Z; Alshaikh S
    Cytojournal; 2019; 16():18. PubMed ID: 31576199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.
    Faquin WC; Wong LQ; Afrogheh AH; Ali SZ; Bishop JA; Bongiovanni M; Pusztaszeri MP; VandenBussche CJ; Gourmaud J; Vaickus LJ; Baloch ZW
    Cancer Cytopathol; 2016 Mar; 124(3):181-7. PubMed ID: 26457584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Study of Bethesda Categories III and IV Thyroid Nodules: Outcomes and Predictive Value of BRAF
    Chirayath SR; Pavithran PV; Abraham N; Nair V; Bhavani N; Kumar H; Menon UV; Menon AS
    Indian J Endocrinol Metab; 2019; 23(3):278-281. PubMed ID: 31641627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance".
    Ohori NP; Nikiforova MN; Schoedel KE; LeBeau SO; Hodak SP; Seethala RR; Carty SE; Ogilvie JB; Yip L; Nikiforov YE
    Cancer Cytopathol; 2010 Feb; 118(1):17-23. PubMed ID: 20099311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RISK OF MALIGNANCY IN THYROID CYTOLOGY: THE IMPACT OF THE RECLASSIFICATION OF NONINVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES (NIFTP).
    Ventura M; Melo M; Fernandes G; Carrilho F
    Endocr Pract; 2019 Jul; 25(7):642-647. PubMed ID: 30865528
    [No Abstract]   [Full Text] [Related]  

  • 15. High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP.
    Özkara SK; Bayrak BY; Turan G
    Diagn Cytopathol; 2020 Nov; 48(11):986-997. PubMed ID: 32745375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of "atypia" in thyroid fine-needle aspiration specimens.
    Kim TH; Krane JF
    Diagn Cytopathol; 2022 Apr; 50(4):146-153. PubMed ID: 34432388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An institutional experience: A retrospective analysis of the effect of transitioning from follicular lesion of undetermined significance to atypia of undetermined significance with subclassified atypia on interobserver concordance, rates of neoplasia, and rates of malignancy.
    Kroll-Wheeler L; Cantley R; Pang JC; Soles BS; Smola B; Jing X; Lew M
    Diagn Cytopathol; 2021 Jan; 49(1):31-38. PubMed ID: 32936526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
    Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
    Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypia of undetermined significance/follicular lesion of undetermined significance: Asian
    Ooi LY; Nga ME
    Gland Surg; 2020 Oct; 9(5):1764-1787. PubMed ID: 33224854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of Subcategory Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Showing Both Cytologic and Architectural Atypia in Thyroid Aspiration Cytology.
    Jung YY; Jung S; Lee HW; Oh YL
    Acta Cytol; 2015; 59(5):370-6. PubMed ID: 26529329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.